HomeProductsBuilding BlocksHeterocyclic ScaffoldsAromatic HeterocyclesAvapritinib
Chemical structure of CAS 1703793-34-3

Avapritinib

CAS No.1703793-34-3
MDL No.MFCD31544325
MFC26H27FN10
MW498.60
InChI KeyDWYRIWUZIJHQKQ-SANMLTNESA-N

Pricing & Availability

Pack SizePurityPriceAvailabilityAction
- -On RequestOn Request
Custom synthesis and bulk supply options are available upon request.

Product Information

CAS No.1703793-34-3
Product NameAvapritinib

Biological Targets

PDGFRA·KIT

Associated Conditions

central nervous system cancer·acute myeloid leukemia·mast-cell leukemia·gastrointestinal stromal tumor·systemic mastocytosis·
* The information provided here is compiled from public sources and is for reference only.

Related Articles

Studies related to this compound and its mechanism of action

The IUPHAR Guide to Immunopharmacology: connecting immunology and pharmacology.

Immunology • Vol. 160, Issue 1 • 2020
PMID: 32020584PMC: PMC7160657DOI: 10.1111/imm.13175

Avapritinib: First Approval.

Drugs • Vol. 80, Issue 4 • 2020
PMID: 32100250DOI: 10.1007/s40265-020-01275-2

Avapritinib: A Selective Inhibitor of KIT and PDGFRα that Reverses ABCB1 and ABCG2-Mediated Multidrug Resistance in Cancer Cell Lines.

Molecular pharmaceutics • Vol. 16, Issue 7 • 2019
PMID: 31117741PMC: PMC6620786DOI: 10.1021/acs.molpharmaceut.9b00274

New frontiers in the medical management of gastrointestinal stromal tumours.

Therapeutic advances in medical oncology • Vol. 11 • 2019
PMID: 31205499PMC: PMC6535752DOI: 10.1177/1758835919841946

Documentation

Similar Products